Panelists in FDA Drug Vote Tied to Makers
Ten Members of FDA Advisory Panel Who Voted to Keep Drug on Market Had Ties to Makers, Report Shows
Associated Press
Washington February 25, 2005
Ten members of the Food and Drug Administration advisory panel who voted that a group of powerful pain killers should continue to be sold had ties to the drug makers, a new analysis shows.
A study by the Center for Science in the Public Interest indicates that 10 of the 32 panel members had ties to either Pfizer Inc., or Merck & Co., ranging from consulting fees and speaking honoraria to receiving research support from the companies.
After three days of hearings on the drugs, known as Cox-2 inhibitors, the panel voted 31-1 to keep Pfizer's Celebrex on the market, 17-13 with 2 abstentions in favor of Pfizer's Bextra and 17-15 that Merck's Vioxx should be allowed back on sale. ... Read this at: http://abcnews.go.com/Politics/wireStory?id=531522
© Virginia Metze
Associated Press
Washington February 25, 2005
Ten members of the Food and Drug Administration advisory panel who voted that a group of powerful pain killers should continue to be sold had ties to the drug makers, a new analysis shows.
A study by the Center for Science in the Public Interest indicates that 10 of the 32 panel members had ties to either Pfizer Inc., or Merck & Co., ranging from consulting fees and speaking honoraria to receiving research support from the companies.
After three days of hearings on the drugs, known as Cox-2 inhibitors, the panel voted 31-1 to keep Pfizer's Celebrex on the market, 17-13 with 2 abstentions in favor of Pfizer's Bextra and 17-15 that Merck's Vioxx should be allowed back on sale. ... Read this at: http://abcnews.go.com/Politics/wireStory?id=531522
© Virginia Metze
Starmail - 27. Feb, 10:04
